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Abstract
Objective: Assess whether reform in the Tanzanian medicines delivery system
from a central ‘push’ kit system to a decentralized ‘pull’ Integrated Logistics
System (ILS) has improved medicines accountability. Methods: Rufiji District in
Tanzania was used as a case study. Data on medicines ordered and patients seen
were compiled from routine information at six public health facilities in 1999
under the kit system and in 2009 under the ILS. Three medicines were included
for comparison: an antimalarial, anthelmintic and oral rehydration salts (ORS).
Results: The quality of the 2009 data was hampered by incorrect quantification
calculations for orders, especially for antimalarials. Between the periods 1999
and 2009, the percent of unaccounted antimalarials fell from 60 to 18%, while
the percent of unaccounted anthelmintic medicines went from 82 to 71%.
Accounting for ORS, on the other hand, did not improve as the unaccounted
amounts increased from 64 to 81% during the same period. Conclusions: The ILS
has not adequately addressed accountability concerns seen under the kit system
due to a combination of governance and system-design challenges. These
quantification weaknesses are likely to have contributed to the frequent periods
of antimalarial stock-out experienced in Tanzania since 2009. We propose
regular reconciliation between the health information system and the medicines
delivery system, thereby improving visibility and guiding interventions to
increase the availability of essential medicines.
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Key Messages
● The transition from a ‘push’ to a ‘pull’ medicines delivery system in
Tanzania was designed in part to increase accountability. At a district
level, we found no evidence of an overall improvement in this dimension
of medicines supply.
● Weaknesses in the design and governance of the ‘pull’ system include the
lack of reconciliation between the medicines delivery system and the
health information system, as well as requiring complex calculations to be
manually completed by health workers every 3 months in a paper-based
system.
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Introduction
The effective delivery of medicines requires integration
and coordination of the entire health system. Policies are
needed that shape the supply systems and its processes;
financial systems are needed to purchase medicines;
trained human resources are needed for procurement and
delivery; health information systems (HISs) are needed to
identify which diseases are prevalent (and therefore the
extent of need); and finally governance is necessary at all
levels to provide oversight and ensure overall availability
and accountability of resources in the system. Medicines
play an integral role in the performance of the health
system (Ruxin et al, 2005; Roberts & Reich, 2011); there-
fore, losses of essential medicines are not only a public
health issue, but are an overall indicator of the ability of
the health system to deliver adequate and quality health
care. Deficits of medicines represent a direct loss of
resources, particularly concerning in low-income coun-
tries like Tanzania where medicines along with medical
supplies constitute the largest discretionary spending in
health and account for approximately 10% of total health
expenditure (Euro Health Group, 2009).
The aim of this study was to investigate how the
medicines delivery system has changed in Tanzania over
the past decade moving from a ‘push’ to a ‘pull’ system.
Our focus was to track the accountability of both systems
by following tracer medicines to establish whether the
governance of the medicines delivery system has been
strengthened as a result of this transition.
Background
Essential drug program (EDP) kit (‘push’ system)
1983–2008
Despite the various waves of decentralization experienced
in Tanzania during the early 1990s, medicines and other
supplies were still centrally provided (‘push’) as standard,
pre-packed EDP ‘kits’ to all health facilities (excluding
hospitals) from the Medical Stores Department (MSD).
The MSD is the national semi-autonomous, non-profit
department under the Ministry of Health and Social Wel-
fare (MoHSW), responsible for the procurement and deliv-
ery of medicines to public and Non-Governmental
Organization health facilities. Kits and the MSD were
established with help from the Danish International
Development Agency, DANIDA, together with UNICEF
and the Government of Tanzania. Kits were colored either
blue or yellow depending on the level of health facility
(dispensary or health center, respectively) and delivered
six times a year (two kits per delivery) (Amenyah et al,
2005). Each kit was designed to last a month, and as they
were procured pre-packed from both international and
national suppliers (Euro Health Group, 2007a) the MSD
only had to manage up to four variants (Center for
Pharmaceutical Management, 2003). The kits contained
35 medicines, 17 medical supply items and 5 stationary
items (United Republic of Tanzania, 1998). Medicines were
selected based on a combination of the National Essential
Drug List of Tanzania (first created in 1991 and updated in
2006) together with national morbidity data. The MSD
delivered kits to the district capital, which had 2 weeks to
distribute the kits to health facilities ensuring their arrival
on the first day of the month (Euro Health Group, 2007a).
A study in 1998 found that nearly all (99%) of the kits
distributed arrived at their destination, suggesting few
were being lost during delivery (Price Waterhouse
Coopers Tanzania, 1999). Nevertheless, the standardized
nature of the kits meant that in some areas certain
medicines were depleted at a faster rate, causing stock-outs
or accumulated surpluses due to differences in catchment
areas and disease burdens (Center for Pharmaceutical
Management, 2003; Amenyah et al, 2005; COWI et al,
2007). To mitigate stock-outs and expired medicines, the
District Medical Officer (DMO) was authorized to reallo-
cate medicines between facilities; however, because of lack
of funds for transport and significant political pressure by
communities not to move medicines away from their local
facilities, redistribution of medicines seldom occurred
(Gilson et al, 1994).
Indent/integrated logistics system (ILS) (‘pull’ system)
2004–present
In early 2000, with support from DANIDA, the Pharma-
ceutical Supply Section (PSS) within the MoHSW designed
a new ‘pull’ system (indent), which included 70 essential
medicines and allowed health facilities (excluding hospi-
tals) to specifically order individual medicines. Vertical
programs such as family planning and specific disease
control programs including sexually transmitted infec-
tions, malaria and HIV remained independent and devel-
oped their own individual supply chains. Under the
indent system, facilities had individual accounts at MSD
and received a standard credit roughly equivalent to three
monthly kits worth every quarter (Boex & Msemo, 2007).
Health facilities were required to estimate quarterly con-
sumption (current ‘stock on hand’ subtracted from quar-
terly monthly consumption) for the 70 items and place
quarterly medicines orders through the district office. The
DMOwas responsible for examining the orders against the
available fund credit and then distributing the packages
upon receipt from MSD. The indent system meant that
MSD moved away from supplying four stock items to
individually packing 70 products in the orders for over
3000 health facilities every month (Center for
Pharmaceutical Management, 2003). As with the kit sys-
tem, health facilities were almost entirely dependent on
the MSD for medicine supplies; a study carried out in
2005/2006 found little difference in medicines availability
between the two systems (Euro Health Group, 2007a).
In 2005, the MoHSW in collaboration with John Snow
Inc’s DELIVER Project expanded the indent ‘pull’ system
to include all vertical programs under the umbrella of the
ILS and rolled it out nationally in 2009. The Expanded
Program of Immunization and the National Tuberculosis
and Leprosy Programs were excluded, however, as they
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were deemed to perform well under their own vertical
programs (Amenyah et al, 2005). The ILS introduced a new
ordering system of 12 forms to be completed by health
facilities. The Request and Report (R&R) form (Figure 1) is
used for quarterly ordering of around 100 pre-determined
priority medicines (all items in the kit were included in
this list). The R&R form contains a fixed algorithm that
requires data from stock ledgers together with physical
counts of inventory to estimate presumed quarterly con-
sumption that is subsequently used to estimate the quan-
tity needed.
From the R&R form, the quantity needed (F) is estimated
using the quarterly consumption (E) divided by three to
attain the monthly consumption, which is multiplied by
seven and from which any stock on hand (D) is deducted.
Health facilities order for 7 months in advance: for the 3
months in a quarter, 2 months for the MSD and district
processing time and the remaining months as a buffer
stock to account for increases in consumption due to
seasonal patterns and any delays in ordering (Amenyah
et al, 2005). The quantity requested is based on quantity
needed (F) and the MSD sale catalogue, which contains
information on pack sizes. The ILS therefore increased
both the number of medicines ordered and the complexity
of the ordering formula.
Completed R&R forms are submitted to the district for
review by both the District Pharmacist and the DMO
before being sent to the MSD. Copies of the R&R form are
kept at the health facility, the office of the DMO and the
MSD. At the district level, health facilities are divided into
three ordering groups submitting R&R forms for the
quarter in different months at different periods to ease
the packaging and processing load at the MSD.
Funds for the purchase of medicines represent a combi-
nation of the district block grant (from government) and a
‘basket fund’ (from donors). The PSS is responsible for
providing oversight on medicines policy and assisting
health facilities to order medicines using the ILS. Alloca-
tion of funds for medicines purchase is based on service
population. On the basis of the recommendations of PSS,
funds are released quarterly by the Ministry of Finance and
Economic Affairs (MoFEA) to health facility accounts in
the MSD via the MoHSW. Funding for medicines is based
on a revolving fund, where once health facilities place
orders with the MSD the funds are released from the
individual accounts and transferred to the MSD working
capital, which can be used for future procurement. The
MSD finances its operating costs by charging a 17.4%
mark-up on all medicines and supplies, except for vertical
programs where the overhead is lower at 14% (Euro Health
Group, 2007b). Health facilities therefore rely almost
entirely on delivery from the MSD, which in turn is reliant
on the timely and complete allocation of funds from the
MoHSW, which relies on the release of funds from the
MoFEA.
MTUHA/Health management and information system
At the national level, the forecasts of the demand for
selected medicines is based on the data collected by the
HIS (or MTUHA as known in Tanzania). The current
MTUHA developed in the early 1990s (Ministry of Health
and Social Welfare Tanzania, 2010) requires health facil-
ities to manually record data in 12 booklets, which contain
forms and registers. This information is summarized quar-
terly and submitted to the office of the DMO for review
before being computerized and made accessible at the
regional level. As the MTUHA system was deemed inade-
quate for some large programs, a number of parallel,
vertical information systems for specific diseases such as
HIV/AIDS, tuberculosis and leprosy have subsequently
been developed (Ministry of Health and Social Welfare
Tanzania, 2007).
Tanzania therefore has two sources of information for
monitoring medicines accountability; on the demand side
they have the HIS (MTUHA), while data on the supply of
medicines come from the ILS at present, and previously
from the EDP kits.
We reconcile these two sources of information from
both medicines delivery systems to determine whether




Our case study is based in the Rufiji District in South East
Tanzania, one of the 132 districts of Tanzania. The Rufiji
District is representative of a rural coastal district in
Tanzania and the district selected by the MoHSW for the
coastal sentinel demographic surveillance system. In 1999,
the Rufiji District, as in the rest of the country, was
receiving medicines through the ‘push’ kit system. At the
same time, Rufiji was one of the two pilot districts (along
with Morogoro District) selected for the ‘Tanzania Essen-
tial Health Interventions Project’ (de Savigny et al, 2008),
which sought to apply the principles and methods of the
1993 World Development Report on evidence-based plan-
ning to guide strategic investments in health based on
burden of disease and cost-effectiveness analyses. We went
to health facilities to collect individual patient data from
Figure 1 Ordering formula used in ILS R&R forms, Tanzania.
Source: Amenyah et al, 2005
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ledger books on patient attendances, diagnoses and corre-
sponding medicines dispensed at the health facility level.
The data collected from facility ledger books were also
compared with summary statistics compiled at the facility
under the MTUHA. Data on medicines stock levels were
taken from health facilities as the sum of the opening
balance inventory carried over to 1999 from the previous
year plus the total amount of medicines received in the kits
(including any other additional medicines received) minus
stock on hand at the end of the year compensating for any
expired medicines removed from inventory during the
year. From this, the amount of medicines specifically
dispensed was compared to identify the fraction of unac-
counted medicines (any consumed medicines that could
not be accounted for inpatient registers). For 1999, this
was conducted in 6 of the 53 public health facilities in
Rufiji using a total of 11 ‘tracer’ medicines: mebendazole;
metronidazole; ferrous sulfate; penicillin V; magnesium
trisilicate; chloroquine; doxycyline; tetracyclin ointment;
aminophylline; and oral rehydration salts (ORS).
‘Pull’ – 2009
In 2009, we replicated the analysis for unaccounted med-
icines in the same six health facilities to determine
whether the amount of unaccounted medicines had chan-
ged following Rufiji’s move, like the rest of the country, to
ILS with training completed in 2009. We used data avail-
able at the district level from both the ILS and theMTUHA.
As a proxy for medicines dispensed, we used the estimated
consumption recorded in the ILS orders. We verified the
reported estimated consumption figure by re-doing the
arithmetic using the data provided (as part of Figure 1). As
we were unable to obtain information about medicines
dispensed, we restricted the sample medicines to those
that were uniquely prescribed for a single disease, therefore
assuming that the medicines would only be used for
treatment of a single disease: artemisinin combination
therapies (ACT) as the first-line treatment for malaria;
albendazole (current anthelmintic) for the treatment of
all protozoan infections; and ORS for diarrhea.
From MTUHA, we obtained annual summaries of out-
patient data collected at the health facility for malaria,
worms and diarrhea.
Results
Reconciliation of medicines supply under the ‘push’
system, 1999
The 1999 results illustrate that the summary health infor-
mation reported under the MTUHA was accurate, with less
than 1% difference in total outpatient numbers compared
with the information collected from the patient ledgers.
Figure 2 illustrates that there were important disparities
between recorded amounts of medicines dispensed and
outpatients recorded for all 11 medicines investigated. We










































































































Figure 2 Reconciliation of medicines received vs medicines dispensed, Rufiji, 1999. Sample of two health centers and five
dispensaries.
Dark bars represent medicines for tracer disease followed in 2009.
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1999; this was most evident in the case of mebendazole
where almost the entire stock (83%) was unaccounted for.
Reconciliation of medicines supply under the ‘pull’
system, 2009
Data gaps existed in the completion of R&R forms where
not one of the six health facilities submitted all four forms
in 2009. As a consequence of data gaps, we combined
quarterly estimated consumption from 2009 and 2010
(Table 1) to estimate a yearly average. Data gaps resulted
in a slight seasonal bias toward dry season orders (Q2 and
Q4) – 10, compared with 9 quarters of rainy season (Q1
and Q3) – however, the impact would be minimized as dry
season orders immediately follow a rainy season.
The second challenge was miscalculation by the health
worker of ‘estimated consumption’ due to arithmetic
errors. These errors in estimated consumption arise from a
number of miscalculations including the addition of extra
zeros, adding the closing balance instead of subtracting it
or counting medicines that had not been recorded as
received (this was especially the case for ACT). Where
arithmetic errors were obvious, they were corrected.
Combining the estimated consumption together with
information from the HIS, we were able to estimate the
amount of unaccounted medicines and then to compare it
with the values from 1999 for the same three classes of
medicines (Table 2).
Antimalarial: The amount of unaccounted antimalarials
was reduced from 60% in 1999 to 18%, 10 years later. The
results are statistically significant at the 95% level.
ORS: The accountability of ORS appears to have deterio-
rated over the past 10 years from 64% unaccounted ORS in
1999 to 81% unaccounted ORS in 2009. The results are
statistically significant at the 95% level.
Anthelmintic: The amount of unaccounted anthelmintic
was reduced from 82% in 1999 to 71%, 10 years later. This
too is statistically significant at the 95% level.
Discussion
As medicines budgets typically constitute a large propor-
tion of discretionary health spending, countries must
ensure that the appropriate quantities of medicines arrive
at health facilities on time, and once there should be
dispensed according to medicines distribution and treat-
ment policies. The current ILS was introduced to provide
routine reporting of data coupled with routine ordering of
resupplies, which enhances accountability and provides the
central level with data for decision making (Amenyah et al,
2005), and indeed has the potential to do so. However,
from the evidence presented here, not one of the surveyed
health facilities studied routinely reported as part of the
ILS and there was no uniform improvement in account-
ability for the three selected ‘tracer’ medicines. Although
accountability of anthelmintic and antimalarial medicines
appears to have improved, the fact remains that still 71
and 18% are unaccounted, respectively, while the account-
ability for ORS appears to have deteriorated. Although
reaching a level of 0% of unaccounted medicines would
be ideal, counting and arithmetic errors are realistically
likely to occur in administrative data. Therefore, for the
purpose of this study, we set a level of 85% accounted
medicines as acceptable. This level reflects the general
uncertainty, inaccuracy and incompleteness of informa-
tion available from routine reporting systems; it is a
generous margin of error and not intended as a gold
standard. The ILS did not reach this level and is therefore
in need of a management response.
Considering that the MSD price of a tin of 100 tablets
of albendazole is currently Tanzanian Shilling (TZS) 1600
(U.S.$ 1.00), TZS 11,000 ($ 7.09) for 100 ORS sachets (MSD
price catalogue 2011) and the government recommended
retail price of a subsidized dose of ACT is TZS 1000 ($0.60)
(Yadav et al, 2012), then the yearly value of the unaccounted
medicines in 2009 was $ 3630 for the six health facilities.
Projected to the Rufiji District level, the annual value of
unaccounted medicines would be around $ 31,500.
Because of the use of secondary data, which in some
instances were incomplete, our study is subject to bias. For
example, the six health facilities were not randomly
selected but selected on the basis of accessibility to facil-
itate data collection. The implication of this could be that
the health facilities were more likely to have a larger flow
of medicines but also more frequented by patients; there-
fore, the bias could move in both directions. We also
assume that each of the three ‘tracer’ medicines is used for
a single disease, yet this may not always be the case.
A possible limitation of our study design is that our
methods rely on different data sources for the amount of
consumed medicines; in 1999, this came directly from
medicines dispensed, while in 2009 this was derived
from estimated consumption. Although demand-driven
Table 1 Quarterly R&R forms submitted across six health facil-
ities, Rufiji, 2009 and 2010
Table 2 Percentage of unaccounted medicines (anthel-
mintic, antimalarial, ORS) in 1999 and 2009 across six
public health facilities in the Rufiji District, Tanzania
Medicine 1999 (95% CI) 2009 (95% CI)
Antimalarial 59.8% (59.7–60.0) 17.8% (17.5–18.2)
ORS 63.8% (63.1–64.5) 80.7% (80.1–81.3)
Anthelmintic 81.9% (81.6–82.1) 71.1% (70.2–72.0)
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(number of patients) information was collected the same
way in both periods (using summary HIS records), we were
only able to verify the accuracy of the 1999 data. The
health information data may have deteriorated over the
years as health workers become increasingly burdened
with the rise in the number of vertical programs and may
not see the purpose of accurately reporting data. Therefore,
a likely contribution to the unaccountability of ‘tracer’
medicines may be that not all patients seen were recorded.
Poor record keeping and late submission of ordering
forms by health facility workers has been found by
others (Euro Health Group, 2007a; Chimnani et al, 2010;
GIZ & Tanzanian German Programme to Support Health
TGPSH, 2011). The lack of capacity of health facility staff
to correctly order and manage medicines was also reported
in a GIZ-funded project assessing 87 health facilities
in four regions in 2011 (GIZ & Tanzanian German
Programme to Support Health TGPSH, 2011). In addition,
the GIZ report found that in some cases during redistribu-
tion of medicines by the District Pharmacists medicines
ledger books were not adjusted. The risk of mistakes in
ordering at the health facility level is accentuated in the
case of ACT due to the four separate doses (based on
patient weight) and because of the seasonality of malaria.
Ordering mistakes could have contributed in part to the
frequent periods of ACT stock-out, which Tanzania has
experienced since 2009 together with other factors such as
delayed procurement and distribution by the MSD due to
lack of funds or capacity.
On the demand side, another limitation could be the
changes in clinical treatment guidelines where, for exam-
ple, in the past albendazole was more readily dispensed, or
changes in patient demands may have resulted in patients
receiving a dose of ACT, ORS or albenzaole even if they
came into the health facility for another purpose.
A contributing factor to some of the ‘tracer’ medicines
not being fully accounted for could be leakage along the
medicines supply chain, perhaps, involving direct pilfer-
age. Incidences of theft of medicines at the health facility
level in Tanzania have frequently been reported in the
press (The Citizen, 2011; Siyame, 2012a); for example, the
Daily News recently described the arrest of several pharma-
cists from a pharmacy owned by employees of the regional
hospital who were discovered selling medicines intended
for the public sector, especially malarial medicines
(Siyame, 2012b). The Audit Report on Global Fund grants
to Tanzania in 2009 reported a comparison between
number of malaria cases and estimated ACT consumed,
which found nearly twice the amount of ACT consumed
for the number of malaria patients, suggesting a ‘leakage’
in the ACT medicines delivery (The Global Fund to Fight
AIDS Tuberculosis and Malaria, 2009). ACTs also have a
much higher resale value than previous antimalarials
(chloroquine) and the street value of ACT would have
increased during periods of national public sector stock-
outs, which may increase the incentive for pilferage. Such
leakages have also been found in other countries; a study
by McPake et al (1999) in Uganda using similar methods to
ours together with qualitative evidence found very high
medicines leakages, which resulted in weaker health
worker performance.
Our results are inconclusive whether the ILS is better or
worse, but emphasize the point that both systems clearly
reveal an unacceptable accountability gap. Two general
obstacles could explain this, the first is complexity in the
design of the logistics system and the second being its
governance. Design weaknesses in the ILS include an
increased work burden on staff by requiring them to make
many difficult calculations for over 100 products every 3
months and submit forms in person to the district capital.
Going to the district capital could mean over a day’s travel
for those working in some remote locations, which would
leave these health facilities without staff during the travel
period. Limitations of health worker capacity were also
found during an evaluation of the ILS pilot in Dodoma and
Iringa regions in 2005 where health workers were failing to
fill in requests for all priority medicines and to submit the
R&R forms on time (Amenyah et al, 2005). These problems
could be mitigated through increased training of staff and
if the ordering was done using mobile phones or digital
devices and the ordering system was simplified, for exam-
ple, with calculations of estimated consumption being
done only once a year and quarterly deliveries from the
MSD being based on these estimates.
The ILS was designed to integrate the vertical programs
with the essential medicines program, but certain vertical
programs such as TB, AIDs and vaccines still operate
separately. These items are delivered through their respec-
tive vertical programs, with additional reporting systems,
which have the potential to create further confusion and
workload for health workers. Integrating these programs
into the ILS would avoid parallel systems and reduce the
burden on health workers to report separately. Design
failures of supply chains in low-income countries have
been identified as one of the most important barriers to
access to medicines (Kraiselburd & Yadav, 2012).
Regarding governance, the ILS appears to have limited
accountability structures. For instance, no individual
(health facility worker or district health official) is held
accountable if an ILS form is not submitted or if repeated
mistakes in calculations are being submitted to the MSD;
gaps in the data hamper efforts toward improving account-
ability. If no order is placed, then no medicines arrive with
the ultimate consequence that the community goes with-
out medicines. Lack of district oversight was also found in
the 2010 evaluation by Chimnani et al (2010). Our study
also found cases where the district resubmitted old forms
with new dates. Achieving accountability requires a degree
of transparency, although the ILS is designed to increase
transparency, if health workers do not complete forms
adequately, then the ILS cannot provide information on
medicines distribution once at the facility level. Data
reconciliation with the HIS (MTUHA) as done in this study
would be a simple way to check the plausibility of medi-
cines ordered. Introducing systematic data reconciliation
between the ILS and the MTUHA would greatly improve
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information on rational medicines consumption. Without
the ability of the ILS to fully account for medicines
ordered, delivered, prescribed and used, the system will
continue to suffer from inherent inconsistencies com-
bined with increasing vulnerability and negligence. In the
case of essential life-saving medicines such as ACT, the
need for accountability is increased to ensure avoidable
mortality is reduced.
At present, Tanzania is investing significant resources
toward a mHealth strategy, which will strengthen some of
the limitations of the ILS under the ‘ILS Gateway’ model, a
USAID-funded project. The ILS Gateway is a mobile
phone-based alert and reporting system for the supply
and logistics of 20 essential health commodities and is
being piloted across 1600 public health facilities. The
mHealth rollout will also include other disease-monitoring
initiatives using mobile phones. Together, these initiatives
should make reconciliation of data easier and highlight
inconsistencies. Another recent change is that the MSD
will deliver directly to health facilities (bypassing the
DMO), making the MSD fully accountable for the entire
supply chain. This, in combination with the mHealth
strategy, is encouraging considering the increasing num-
ber of new initiatives (medicines donations and low-cost
access initiatives) together with an expected rise in the
number of health facilities (7000 by mid 2013), both of
which may augment the workload and complexity at the
MSD, increasing the need for a reliable reporting system.
Conclusion
The availability of medicines at health facilities is a critical
element of service delivery quality, without which the
districts will be seriously limited in their ability to provide
adequate health care. To our knowledge, this study is the
first to critically examine the availability of medicines
under the current logistics supply system compared with
the previous kit system. This study suggests that there is an
opportunity to reconcile information on the demand for
essential medicines with their supply. This approach could
be a way of exploring the accountability of resources in a
health system, which was not exploited under either
medicines delivery system. Of the three medicines we
compared, absolute accountability rates were still low in
the ILS, with around 20 to 80% of medicines not being
accounted for, and with one tracer (ORS) experiencing a
deterioration in accountability compared with the pre-
vious kit system. Such degrees of unaccountability in the
distribution of medicines suggest that the ILS is unable to
effectively monitor the supply and use of medicines, thus
facilitating a health system environment in which obfus-
cation can occur and in which performance can go
unrewarded. Although the ILS was designed to increase
accountability and to reduce wastage of resources, its
overly complex and ‘paper-driven’ design together with
other factors such as limited regular staff training and
supervision has constrained it from fully achieving these
targets. As essential medicines constitute a key component
of service delivery quality, which in turn is critical for
improving effective access, urgent system design and
governance interventions need to be developed to funda-
mentally strengthen this critical aspect of the health
system.
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